Theagene Jean-Manasse

Theagene Jean-Manasse is listed in filings as Director at MAIA Biotechnology, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including 8 public disclosures. Recent filings connect the profile to MAIA Biotechnology, Inc. (MAIA). The current snapshot covers public activity from Jul 2, 2024 to Apr 2, 2026. Reported amounts are shown as $38.2K to $36.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.